Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis with Dr. Peter Merkel

The ADVOCATE Trial: A Conversation with Dr. Peter A. MerkelПодробнее

KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and TreatmentПодробнее

Researcher comment: The ADVOCATE trial | Peter MerkelПодробнее

Granulomatosis with PolyangiitisПодробнее

ANCA-Associated Vasculitis Treatment in 2022 - Prof. Jayne (Cambridge)Подробнее

CanVasc Consensus Recommendations for the Management of ANCA-associated Vasculitis: Arielle MendelПодробнее

Dr. Peter A. Merkel of UPenn on Vasculitis Clinical Research Consortium (VCRC)Подробнее

ANCA Associated Vasculitis (Anti-Neutrophil Cytoplasmic Antibody) - Causes, Pathophysiology, TypesПодробнее

Clinical Trials in Vasculitis: What's New, What's for YouПодробнее

Opportunities to Further Care in ANCA-Associated Vasculitis: GPA and MPAПодробнее

Understanding Challenges in Traditional Care of ANCA-Associated Vasculitis: GPA and MPAПодробнее

ANCA-associated Vasculitis: Update Therapy 2023 - Prof. Dr. Alexandre Karras (Paris, France)Подробнее

KDIGO 2024 ANCA Vasculitis Guideline: Reading Between the LinesПодробнее

ANCA Associated Vasculitis From Renal Perspective - Dr. Mohamed Mamdouh AbdalbaryПодробнее

Update on ANCA Associated VasculitisПодробнее

Research Insights: Precision Medicine in the Treatment of ANCA-associated VasculitisПодробнее

Current issues in ANCA associated vasculitisПодробнее

Rheumatology Patient Education: ANCA-Associated VasculitisПодробнее

Evaluation and Early Diagnosis of ANCA Associated Vasculitis (AAV) (ERN-RITA Webinar)Подробнее